A key concept in drug discovery is the identification of candidate therapeutic targets such as
long noncoding RNAs (lncRNAs) because of their extensive involvement in neoplasms, and …

MicroRNAs (miRNAs) are a class of non-coding RNAs of about 20 nucleotides in length,
involved in the regulation of many biochemical pathways in the human body. The level of …

Myocarditis is a disease caused by cardiac inflammation that can progress to dilated
cardiomyopathy, heart failure, and eventually death. Several etiologies, including …

Myocarditis and inflammatory dilated cardiomyopathy are cardiac diseases leading to heart
failure. Liquid biopsy is a concept of replacing traditional biopsy with specialized blood tests …

Heart failure is a leading cause of morbidity and mortality, with relevant social and economic
burden on global healthcare system. Although the development of novel diagnostic tools …

Background Cardiac‐resident or‐enriched microRNAs (miRNAs) could be released into the
bloodstream becoming circulating cardiac miRNAs, which are increasingly recognized as …

Dilated cardiomyopathy (DCM) is a clinical diagnosis characterized by left ventricular or
biventricular dilation and systolic dysfunction. In most cases, DCM is progressive, leading to …

Aims Cardiomyocyte apoptosis is an important factor leading to the occurrence and
development of heart failure (HF), which is associated with high mortality of patients with …

Cardiovascular diseases (CVD) are a group of disorders that affect the heart and blood
vessels. They include conditions such as myocardial infarction, coronary artery disease …

Our understanding of dilated cardiomyopathy (DCM) is evolving as new insights into the
underlying pathophysiology become available. Professional organizations and clinical …